Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Related structures:
AlphaFold database: A4HN05
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 12 |
GO:0006370 | 7-methylguanosine mRNA capping | 8 | 12 |
GO:0006396 | RNA processing | 6 | 12 |
GO:0006397 | mRNA processing | 7 | 12 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 12 |
GO:0006807 | nitrogen compound metabolic process | 2 | 12 |
GO:0008152 | metabolic process | 1 | 12 |
GO:0009452 | 7-methylguanosine RNA capping | 8 | 12 |
GO:0009987 | cellular process | 1 | 12 |
GO:0016070 | RNA metabolic process | 5 | 12 |
GO:0016071 | mRNA metabolic process | 6 | 12 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 12 |
GO:0036260 | RNA capping | 7 | 12 |
GO:0043170 | macromolecule metabolic process | 3 | 12 |
GO:0044237 | cellular metabolic process | 2 | 12 |
GO:0044238 | primary metabolic process | 2 | 12 |
GO:0046483 | heterocycle metabolic process | 3 | 12 |
GO:0071704 | organic substance metabolic process | 2 | 12 |
GO:0090304 | nucleic acid metabolic process | 4 | 12 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 12 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 11 |
GO:0003746 | translation elongation factor activity | 4 | 11 |
GO:0003824 | catalytic activity | 1 | 12 |
GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity | 6 | 12 |
GO:0005488 | binding | 1 | 11 |
GO:0008135 | translation factor activity, RNA binding | 3 | 11 |
GO:0008168 | methyltransferase activity | 4 | 12 |
GO:0008171 | O-methyltransferase activity | 5 | 12 |
GO:0008173 | RNA methyltransferase activity | 4 | 12 |
GO:0008174 | mRNA methyltransferase activity | 5 | 12 |
GO:0008757 | S-adenosylmethionine-dependent methyltransferase activity | 5 | 12 |
GO:0016740 | transferase activity | 2 | 12 |
GO:0016741 | transferase activity, transferring one-carbon groups | 3 | 12 |
GO:0045182 | translation regulator activity | 1 | 11 |
GO:0090079 | translation regulator activity, nucleic acid binding | 2 | 11 |
GO:0097159 | organic cyclic compound binding | 2 | 11 |
GO:0140098 | catalytic activity, acting on RNA | 3 | 12 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 12 |
GO:1901363 | heterocyclic compound binding | 2 | 11 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 456 | 460 | PF00656 | 0.479 |
CLV_NRD_NRD_1 | 164 | 166 | PF00675 | 0.320 |
CLV_NRD_NRD_1 | 409 | 411 | PF00675 | 0.455 |
CLV_NRD_NRD_1 | 434 | 436 | PF00675 | 0.397 |
CLV_NRD_NRD_1 | 7 | 9 | PF00675 | 0.537 |
CLV_NRD_NRD_1 | 80 | 82 | PF00675 | 0.297 |
CLV_PCSK_KEX2_1 | 11 | 13 | PF00082 | 0.419 |
CLV_PCSK_KEX2_1 | 164 | 166 | PF00082 | 0.320 |
CLV_PCSK_KEX2_1 | 40 | 42 | PF00082 | 0.293 |
CLV_PCSK_KEX2_1 | 433 | 435 | PF00082 | 0.451 |
CLV_PCSK_KEX2_1 | 444 | 446 | PF00082 | 0.530 |
CLV_PCSK_KEX2_1 | 7 | 9 | PF00082 | 0.454 |
CLV_PCSK_PC1ET2_1 | 11 | 13 | PF00082 | 0.419 |
CLV_PCSK_PC1ET2_1 | 40 | 42 | PF00082 | 0.293 |
CLV_PCSK_PC1ET2_1 | 444 | 446 | PF00082 | 0.374 |
CLV_PCSK_PC1ET2_1 | 7 | 9 | PF00082 | 0.454 |
CLV_PCSK_SKI1_1 | 137 | 141 | PF00082 | 0.289 |
CLV_PCSK_SKI1_1 | 164 | 168 | PF00082 | 0.491 |
CLV_PCSK_SKI1_1 | 238 | 242 | PF00082 | 0.326 |
CLV_PCSK_SKI1_1 | 37 | 41 | PF00082 | 0.588 |
CLV_PCSK_SKI1_1 | 402 | 406 | PF00082 | 0.507 |
CLV_PCSK_SKI1_1 | 411 | 415 | PF00082 | 0.365 |
CLV_PCSK_SKI1_1 | 435 | 439 | PF00082 | 0.448 |
CLV_PCSK_SKI1_1 | 70 | 74 | PF00082 | 0.381 |
CLV_PCSK_SKI1_1 | 81 | 85 | PF00082 | 0.249 |
CLV_Separin_Metazoa | 412 | 416 | PF03568 | 0.490 |
DOC_CYCLIN_RxL_1 | 235 | 245 | PF00134 | 0.311 |
DOC_CYCLIN_RxL_1 | 77 | 87 | PF00134 | 0.318 |
DOC_MAPK_DCC_7 | 165 | 175 | PF00069 | 0.412 |
DOC_MAPK_gen_1 | 236 | 243 | PF00069 | 0.331 |
DOC_MAPK_gen_1 | 360 | 367 | PF00069 | 0.338 |
DOC_MAPK_gen_1 | 410 | 416 | PF00069 | 0.503 |
DOC_MAPK_gen_1 | 433 | 440 | PF00069 | 0.407 |
DOC_MAPK_MEF2A_6 | 224 | 232 | PF00069 | 0.374 |
DOC_MAPK_MEF2A_6 | 236 | 243 | PF00069 | 0.387 |
DOC_MAPK_MEF2A_6 | 316 | 323 | PF00069 | 0.356 |
DOC_MAPK_NFAT4_5 | 316 | 324 | PF00069 | 0.380 |
DOC_PP1_RVXF_1 | 236 | 243 | PF00149 | 0.330 |
DOC_PP2B_LxvP_1 | 220 | 223 | PF13499 | 0.395 |
DOC_PP2B_LxvP_1 | 319 | 322 | PF13499 | 0.414 |
DOC_PP2B_LxvP_1 | 334 | 337 | PF13499 | 0.351 |
DOC_PP4_FxxP_1 | 283 | 286 | PF00568 | 0.335 |
DOC_PP4_FxxP_1 | 396 | 399 | PF00568 | 0.369 |
DOC_USP7_MATH_1 | 181 | 185 | PF00917 | 0.383 |
DOC_USP7_MATH_1 | 286 | 290 | PF00917 | 0.498 |
DOC_USP7_MATH_1 | 64 | 68 | PF00917 | 0.434 |
DOC_USP7_MATH_1 | 97 | 101 | PF00917 | 0.205 |
DOC_USP7_UBL2_3 | 7 | 11 | PF12436 | 0.356 |
DOC_WW_Pin1_4 | 24 | 29 | PF00397 | 0.477 |
LIG_14-3-3_CanoR_1 | 124 | 128 | PF00244 | 0.312 |
LIG_14-3-3_CanoR_1 | 164 | 173 | PF00244 | 0.426 |
LIG_14-3-3_CanoR_1 | 284 | 294 | PF00244 | 0.451 |
LIG_14-3-3_CanoR_1 | 326 | 336 | PF00244 | 0.356 |
LIG_14-3-3_CanoR_1 | 507 | 512 | PF00244 | 0.407 |
LIG_14-3-3_CanoR_1 | 96 | 102 | PF00244 | 0.303 |
LIG_Actin_WH2_2 | 387 | 404 | PF00022 | 0.426 |
LIG_APCC_ABBA_1 | 370 | 375 | PF00400 | 0.321 |
LIG_BIR_III_4 | 457 | 461 | PF00653 | 0.554 |
LIG_BRCT_BRCA1_1 | 470 | 474 | PF00533 | 0.436 |
LIG_BRCT_BRCA1_1 | 48 | 52 | PF00533 | 0.510 |
LIG_CaM_IQ_9 | 182 | 197 | PF13499 | 0.483 |
LIG_eIF4E_1 | 314 | 320 | PF01652 | 0.427 |
LIG_FHA_1 | 124 | 130 | PF00498 | 0.294 |
LIG_FHA_1 | 165 | 171 | PF00498 | 0.490 |
LIG_FHA_1 | 200 | 206 | PF00498 | 0.448 |
LIG_FHA_1 | 207 | 213 | PF00498 | 0.445 |
LIG_FHA_1 | 269 | 275 | PF00498 | 0.459 |
LIG_FHA_1 | 301 | 307 | PF00498 | 0.573 |
LIG_FHA_1 | 404 | 410 | PF00498 | 0.508 |
LIG_FHA_1 | 419 | 425 | PF00498 | 0.269 |
LIG_FHA_1 | 517 | 523 | PF00498 | 0.395 |
LIG_FHA_2 | 326 | 332 | PF00498 | 0.334 |
LIG_FHA_2 | 346 | 352 | PF00498 | 0.361 |
LIG_FHA_2 | 425 | 431 | PF00498 | 0.430 |
LIG_FHA_2 | 488 | 494 | PF00498 | 0.477 |
LIG_GBD_Chelix_1 | 416 | 424 | PF00786 | 0.424 |
LIG_HCF-1_HBM_1 | 378 | 381 | PF13415 | 0.357 |
LIG_Integrin_RGD_1 | 316 | 318 | PF01839 | 0.407 |
LIG_IRF3_LxIS_1 | 239 | 244 | PF10401 | 0.442 |
LIG_LIR_Apic_2 | 42 | 47 | PF02991 | 0.417 |
LIG_LIR_Gen_1 | 100 | 109 | PF02991 | 0.309 |
LIG_LIR_Gen_1 | 126 | 135 | PF02991 | 0.276 |
LIG_LIR_Gen_1 | 18 | 28 | PF02991 | 0.493 |
LIG_LIR_Gen_1 | 268 | 274 | PF02991 | 0.347 |
LIG_LIR_Gen_1 | 33 | 43 | PF02991 | 0.266 |
LIG_LIR_Gen_1 | 392 | 401 | PF02991 | 0.392 |
LIG_LIR_LC3C_4 | 331 | 336 | PF02991 | 0.325 |
LIG_LIR_Nem_3 | 100 | 104 | PF02991 | 0.290 |
LIG_LIR_Nem_3 | 126 | 130 | PF02991 | 0.276 |
LIG_LIR_Nem_3 | 18 | 23 | PF02991 | 0.482 |
LIG_LIR_Nem_3 | 268 | 273 | PF02991 | 0.351 |
LIG_LIR_Nem_3 | 33 | 38 | PF02991 | 0.268 |
LIG_LIR_Nem_3 | 351 | 357 | PF02991 | 0.336 |
LIG_LIR_Nem_3 | 392 | 396 | PF02991 | 0.374 |
LIG_LIR_Nem_3 | 49 | 55 | PF02991 | 0.386 |
LIG_PCNA_PIPBox_1 | 13 | 22 | PF02747 | 0.542 |
LIG_PCNA_yPIPBox_3 | 7 | 20 | PF02747 | 0.555 |
LIG_PTB_Apo_2 | 14 | 21 | PF02174 | 0.544 |
LIG_PTB_Apo_2 | 147 | 154 | PF02174 | 0.274 |
LIG_PTB_Phospho_1 | 14 | 20 | PF10480 | 0.543 |
LIG_REV1ctd_RIR_1 | 354 | 364 | PF16727 | 0.311 |
LIG_SH2_CRK | 101 | 105 | PF00017 | 0.308 |
LIG_SH2_CRK | 44 | 48 | PF00017 | 0.421 |
LIG_SH2_CRK | 94 | 98 | PF00017 | 0.264 |
LIG_SH2_NCK_1 | 381 | 385 | PF00017 | 0.338 |
LIG_SH2_SRC | 177 | 180 | PF00017 | 0.414 |
LIG_SH2_STAP1 | 159 | 163 | PF00017 | 0.272 |
LIG_SH2_STAP1 | 20 | 24 | PF00017 | 0.420 |
LIG_SH2_STAP1 | 381 | 385 | PF00017 | 0.338 |
LIG_SH2_STAT3 | 294 | 297 | PF00017 | 0.427 |
LIG_SH2_STAT5 | 287 | 290 | PF00017 | 0.412 |
LIG_SH2_STAT5 | 314 | 317 | PF00017 | 0.363 |
LIG_SH2_STAT5 | 393 | 396 | PF00017 | 0.385 |
LIG_SH2_STAT5 | 5 | 8 | PF00017 | 0.632 |
LIG_SH2_STAT5 | 94 | 97 | PF00017 | 0.340 |
LIG_SH3_2 | 61 | 66 | PF14604 | 0.432 |
LIG_SH3_3 | 136 | 142 | PF00018 | 0.363 |
LIG_SH3_3 | 248 | 254 | PF00018 | 0.483 |
LIG_SH3_3 | 58 | 64 | PF00018 | 0.431 |
LIG_TYR_ITIM | 99 | 104 | PF00017 | 0.340 |
MOD_CK1_1 | 289 | 295 | PF00069 | 0.557 |
MOD_CK1_1 | 480 | 486 | PF00069 | 0.727 |
MOD_CK1_1 | 528 | 534 | PF00069 | 0.586 |
MOD_CK2_1 | 325 | 331 | PF00069 | 0.332 |
MOD_CK2_1 | 345 | 351 | PF00069 | 0.396 |
MOD_CK2_1 | 416 | 422 | PF00069 | 0.505 |
MOD_CK2_1 | 487 | 493 | PF00069 | 0.633 |
MOD_GlcNHglycan | 2 | 5 | PF01048 | 0.643 |
MOD_GlcNHglycan | 20 | 23 | PF01048 | 0.334 |
MOD_GlcNHglycan | 247 | 250 | PF01048 | 0.381 |
MOD_GlcNHglycan | 470 | 473 | PF01048 | 0.602 |
MOD_GlcNHglycan | 482 | 485 | PF01048 | 0.532 |
MOD_GlcNHglycan | 530 | 533 | PF01048 | 0.522 |
MOD_GlcNHglycan | 73 | 76 | PF01048 | 0.417 |
MOD_GSK3_1 | 18 | 25 | PF00069 | 0.474 |
MOD_GSK3_1 | 241 | 248 | PF00069 | 0.330 |
MOD_GSK3_1 | 285 | 292 | PF00069 | 0.512 |
MOD_GSK3_1 | 322 | 329 | PF00069 | 0.326 |
MOD_GSK3_1 | 473 | 480 | PF00069 | 0.622 |
MOD_GSK3_1 | 482 | 489 | PF00069 | 0.672 |
MOD_N-GLC_1 | 154 | 159 | PF02516 | 0.289 |
MOD_N-GLC_1 | 345 | 350 | PF02516 | 0.399 |
MOD_N-GLC_1 | 445 | 450 | PF02516 | 0.429 |
MOD_N-GLC_2 | 475 | 477 | PF02516 | 0.472 |
MOD_NEK2_1 | 23 | 28 | PF00069 | 0.588 |
MOD_NEK2_1 | 356 | 361 | PF00069 | 0.451 |
MOD_NEK2_1 | 533 | 538 | PF00069 | 0.585 |
MOD_PK_1 | 247 | 253 | PF00069 | 0.428 |
MOD_PKA_1 | 164 | 170 | PF00069 | 0.418 |
MOD_PKA_2 | 123 | 129 | PF00069 | 0.308 |
MOD_PKA_2 | 164 | 170 | PF00069 | 0.384 |
MOD_PKA_2 | 206 | 212 | PF00069 | 0.497 |
MOD_PKA_2 | 300 | 306 | PF00069 | 0.546 |
MOD_PKA_2 | 325 | 331 | PF00069 | 0.332 |
MOD_PKA_2 | 480 | 486 | PF00069 | 0.602 |
MOD_PKA_2 | 506 | 512 | PF00069 | 0.497 |
MOD_Plk_1 | 154 | 160 | PF00069 | 0.315 |
MOD_Plk_1 | 276 | 282 | PF00069 | 0.403 |
MOD_Plk_1 | 345 | 351 | PF00069 | 0.396 |
MOD_Plk_1 | 498 | 504 | PF00069 | 0.545 |
MOD_Plk_2-3 | 482 | 488 | PF00069 | 0.500 |
MOD_Plk_2-3 | 493 | 499 | PF00069 | 0.390 |
MOD_Plk_4 | 276 | 282 | PF00069 | 0.403 |
MOD_Plk_4 | 389 | 395 | PF00069 | 0.366 |
MOD_ProDKin_1 | 24 | 30 | PF00069 | 0.474 |
MOD_SUMO_rev_2 | 183 | 192 | PF00179 | 0.555 |
MOD_SUMO_rev_2 | 462 | 472 | PF00179 | 0.650 |
MOD_SUMO_rev_2 | 67 | 75 | PF00179 | 0.308 |
TRG_DiLeu_BaEn_1 | 386 | 391 | PF01217 | 0.392 |
TRG_DiLeu_BaLyEn_6 | 236 | 241 | PF01217 | 0.381 |
TRG_DiLeu_BaLyEn_6 | 301 | 306 | PF01217 | 0.557 |
TRG_ENDOCYTIC_2 | 101 | 104 | PF00928 | 0.303 |
TRG_ENDOCYTIC_2 | 177 | 180 | PF00928 | 0.311 |
TRG_ENDOCYTIC_2 | 20 | 23 | PF00928 | 0.611 |
TRG_ENDOCYTIC_2 | 393 | 396 | PF00928 | 0.346 |
TRG_ER_diArg_1 | 164 | 166 | PF00400 | 0.232 |
TRG_ER_diArg_1 | 433 | 435 | PF00400 | 0.413 |
TRG_ER_diArg_1 | 513 | 516 | PF00400 | 0.340 |
TRG_ER_diArg_1 | 65 | 68 | PF00400 | 0.325 |
TRG_ER_FFAT_2 | 14 | 25 | PF00635 | 0.479 |
TRG_NLS_MonoCore_2 | 6 | 11 | PF00514 | 0.522 |
TRG_NLS_MonoExtC_3 | 6 | 11 | PF00514 | 0.463 |
TRG_NLS_MonoExtN_4 | 7 | 13 | PF00514 | 0.509 |
TRG_Pf-PMV_PEXEL_1 | 164 | 168 | PF00026 | 0.384 |
TRG_Pf-PMV_PEXEL_1 | 304 | 308 | PF00026 | 0.540 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PB31 | Leptomonas seymouri | 75% | 100% |
A0A0S4IHM6 | Bodo saltans | 54% | 100% |
A0A0S4JS06 | Bodo saltans | 43% | 100% |
A0A1X0P597 | Trypanosomatidae | 62% | 100% |
A0A3S7X9K6 | Leishmania donovani | 87% | 99% |
A0A422NR92 | Trypanosoma rangeli | 59% | 100% |
A4IBM8 | Leishmania infantum | 88% | 99% |
C9ZZ04 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 59% | 100% |
E9AFG2 | Leishmania major | 87% | 100% |
E9B6L7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 87% | 99% |